SCOPUS 정보 검색 플랫폼

American Journal of Cardiology

Volumn 94, Issue 10, 2004, Pages 1306-1310

Effect of atorvastatin on left ventricular diastolic function and ability of coenzyme Q 10 to reverse that dysfunction

(5) Silver, Marc A a,b Langsjoen, Peter H d Szabo, Szabolcs c Patil, Harish c Zelinger, Allan b

a Heart Failure Institute (United States)

b ADVOCATE CHRIST MEDICAL CENTER (United States)

c Univ Illinois Christ Cardiovasc D (United States)

d EAST TEXAS MEDICAL CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; UBIDECARENONE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DIABETES MELLITUS; DIASTOLE; DISEASE ASSOCIATION; DISEASE COURSE; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFECT; DRUG MECHANISM; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE PERFORMANCE; HUMAN; HYPERTENSION; MALE; PARAMETER; PATIENT SELECTION; PRIORITY JOURNAL; SIDE EFFECT; STATISTICAL SIGNIFICANCE;

AGED; ANTICHOLESTEREMIC AGENTS; ANTIOXIDANTS; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PYRROLES; UBIQUINONE; VENTRICULAR FUNCTION, LEFT;

EID: 7944221535 PISSN: 00029149 EISSN: None Source Type: Journal
DOI: 10.1016/j.amjcard.2004.07.121 Document Type: Article

Times cited : (90)

References (11)

1
- 0347419377
- The clinical use of HMG CoA-reductase inhibitors and the associated depletion of coenzyme Q10: A review of animal and human publications
- P.H. Langsjoen, A.M. Langsjoen The clinical use of HMG CoA-reductase inhibitors and the associated depletion of coenzyme Q10 A review of animal and human publications BioFactors 18 2003 101 111
- (2003) BioFactors , vol.18 , pp. 101-111
- Langsjoen, P.H.¹ Langsjoen, A.M.²

2
- 2942587374
- Atorvastatin decreases the conenzyme Q 10 level in the blood of patients at risk for cardiovascular disease and stroke
- T. Rundek, A. Naini, R. Sacco, K. Coates, S. DiMauro Atorvastatin decreases the conenzyme Q 10 level in the blood of patients at risk for cardiovascular disease and stroke Arch Neurol 61 2004 889 892
- (2004) Arch Neurol , vol.61 , pp. 889-892
- Rundek, T.¹ Naini, A.² Sacco, R.³ Coates, K.⁴ Dimauro, S.⁵

3
- 0037094219
- Statins and chronic heart failure: Do we need a large-scale outcome trial?
- H. Krum, J.J. McMurray Statins and chronic heart failure: do we need a large-scale outcome trial? J Am Coll Cardiol 39 2002 1567 1573
- (2002) J Am Coll Cardiol , vol.39 , pp. 1567-1573
- Krum, H.¹ McMurray, J.J.²

4
- 0027158373
- Evidence of plasma CoQ10 lowering effect by HMG-CoA reductase inhibitors: Double blind placebo controlled study
- G. Ghirlanda, A. Oradei, A. Manto, S. Lippa, L. Uccioli, S. Caputo, A.V. Greco, G.P. Littarru Evidence of plasma CoQ10 lowering effect by HMG-CoA reductase inhibitors: double blind placebo controlled study J Clin Pharmacol 33 1993 226 229
- (1993) J Clin Pharmacol , vol.33 , pp. 226-229
- Ghirlanda, G.¹ Oradei, A.² Manto, A.³ Lippa, S.⁴ Uccioli, L.⁵ Caputo, S.⁶ Greco, A.V.⁷ Littarru, G.P.⁸

5
- 0030770430
- Dose related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors
- S.A. Mortensen, A. Leth, E. Agner, M. Rohde Dose related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors Mol Aspects Med 18 suppl 1997 S137 S144
- (1997) Mol Aspects Med , vol.18
- Mortensen, S.A.¹ Leth, A.² Agner, E.³ Rohde, M.⁴

6
- 0028725070
- Exogenous CoQ10 preserves plasma ubiqinone levels inpatients treated with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors
- A.M. Bargossi, M. Battino, A. Gaddi, P.L. Fiorella, G. Grossi, G. Barozzi, R. Di Giulio, G. Descovich, S. Sassi, M.L. Genova Exogenous CoQ10 preserves plasma ubiqinone levels inpatients treated with 3-hydroxy-3- methylglutaryl coenzyme A reductase inhibitors Int J Clin Lab Res 24 1994 171 176
- (1994) Int J Clin Lab Res , vol.24 , pp. 171-176
- Bargossi, A.M.¹ Battino, M.² Gaddi, A.³ Fiorella, P.L.⁴ Grossi, G.⁵ Barozzi, G.⁶ Di Giulio, R.⁷ Descovich, G.⁸ Sassi, S.⁹ Genova, M.L.¹⁰

7
- 0037420492
- Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial
- ASCOT Investigators G.T.
- P.S. Sever, B. Dahlof, N.R. Poulter, H. Wedel, G. Beevers, M. Caulfield, R. Collins, S.E. Kjeldsen, A. Kristinsson, G.T McInnes ASCOT Investigators Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial Lancet 361 2003 1149 1158
- (2003) Lancet , vol.361 , pp. 1149-1158
- Sever, P.S.¹ Dahlof, B.² Poulter, N.R.³ Wedel, H.⁴ Beevers, G.⁵ Caulfield, M.⁶ Collins, R.⁷ Kjeldsen, S.E.⁸ Kristinsson, A.⁹ McInnes¹⁰

8
- 0036023515
- Treatment with atorvastatin to the National Cholesterol Educational Program goal versus usual care in secondary coronary heart disease prevention: The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study
- V.G. Athyros, A.A. Papageorgiou, B.R. Mercouris, V.V. Athyrou, A.N. Symeonidis, E.O. Basayannis, D.S. Demitriadis, A.G. Kontopoulos Treatment with atorvastatin to the National Cholesterol Educational Program goal versus usual care in secondary coronary heart disease prevention The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study Curr Med Res Opin 18 2002 220 228
- (2002) Curr Med Res Opin , vol.18 , pp. 220-228
- Athyros, V.G.¹ Papageorgiou, A.A.² Mercouris, B.R.³ Athyrou, V.V.⁴ Symeonidis, A.N.⁵ Basayannis, E.O.⁶ Demitriadis, D.S.⁷ Kontopoulos, A.G.⁸

9
- 0041508596
- Effect of atorvastatin on myocardial contractile reserve assessed by tissue Doppler imaging in moderately hypercholesterolemic patients without heart disease
- M. Bountioukos, V. Rizzello, B.J. Krenning, J.J. Bax, M.D. Kertai, E.C. Vourvouri, A.F. Schinkel, E. Biagini, E. Boersma, J.R Roelandt Effect of atorvastatin on myocardial contractile reserve assessed by tissue Doppler imaging in moderately hypercholesterolemic patients without heart disease Am J Cardiol 92 2003 613 616
- (2003) Am J Cardiol , vol.92 , pp. 613-616
- Bountioukos, M.¹ Rizzello, V.² Krenning, B.J.³ Bax, J.J.⁴ Kertai, M.D.⁵ Vourvouri, E.C.⁶ Schinkel, A.F.⁷ Biagini, E.⁸ Boersma, E.⁹ Roelandt, J.R.¹⁰

10
- 0027194779
- Isolated diastolic dysfunction of the myocardium and its response to CoQ10 treatment
- P.H. Langsjoen, P.H. Langsjoen, K. Folkers Isolated diastolic dysfunction of the myocardium and its response to CoQ10 treatment Clin Invest 71 suppl 1993 S140 S144
- (1993) Clin Invest , vol.71
- Langsjoen, P.H.¹ Langsjoen, P.H.² Folkers, K.³

11
- 0028648884
- Recovery of load-induced left ventricular diastolic dysfunction by coenzyme Q10: Echocardiographic study
- T. Oda Recovery of load-induced left ventricular diastolic dysfunction by coenzyme Q10: echocardiographic study Mol Aspects Med 15 suppl 1994 S149 S154
- (1994) Mol Aspects Med , vol.15
- Oda, T.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.